Skip to search formSkip to main contentSkip to account menu

pan-PI3K Inhibitor CLR457

Known as: CLR457 
An orally bioavailable pan inhibitor of phosphatidylinositol-3-kinase (PI3K), with potential antineoplastic activity. Upon oral administration, pan… 
National Institutes of Health

Search for papers about pan-PI3K Inhibitor CLR457

Search papers